An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Clinical trial NCT02407223 · TERMINATED
Trial details
- NCT number
- NCT02407223
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-13
- Primary completion
- 2017-09-26
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.